Abstract
Background:Management of rheumatoid arthritis (RA) has improved dramatically due to early diagnosis, treat-to-target approaches based on disease activity measures, and the introduction of biological disease modifying anti-rheumatic drugs (bDMARDs). Tumor...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
